|  HOME  | ABOUT  |   EVENTS  |  NEWS  |  REPORTS  |  CONTACT  | MULTIMEDIA |


Events


International Consultative Workshop:
An emergency public health response to the combined DR-TB and HIV/AIDS crisis in the southern African Region

Dates:
28th, 29th and 30th October 2009
Venue:
Esibayeni Lodge, Manzini Region, Swaziland

Click here for the briefing document.


Introduction

The goal of the workshop is to define the best operational strategies and technical choices for the implementation of a decentralized model of care in rural settings affected by high HIV and (DR)-TB prevalence, taking Shiselweni region of Swaziland as a case in point.

Workshop Programme Overview

All sessions feature some of the world’s most distinguished researchers, scientific leaders and clinical specialists on Tuberculosis and HIV/AIDS together with Ministry of Health representatives from the Southern African region. World Health Organisation specialists together with Non Governmental Organisations representatives, Médecins Sans Frontières specialists, People Live with HIV/AIDS and other representatives of the civil society complete the workshop panel.

Plenary Sessions bring together all the workshop delegates at the first day for the opening presentations.

Bridging Sessions connect the different sessions to provide an opportunity for dialogue on topics of common interest during the second day.

Closing Session at the third day will have the Rapporteurs’ summaries and the Final Wrap Up focusing on critical issues addressed and key recommendations put forward.

Session organisation Each session will have a session chairperson. An initial speaker will deliver a fifteen-minute presentation followed by guided discussion focused on each session objectives. Additional presentations will take place in different sessions to present the South African regional experience. All sessions will be video recorded and the Rapporteurs will ensure the synthesis of the different opinions and recommendations.

Outline

Wednesday 28 October | Plenary Session

Venue: Session Room 1 – Left Wing
09:00-13:00                             Opening Session
14:00-17:30                             Intro Session 1: Health System

Thursday 29 October | Sessions

Venue: Session Room 7
09:00-13:00                             Session 1: Health System
14:00-18:00                             Session 1: Health System

Bridging Sessions
Venue: Session Room 10
09:00-13:00                             Session 2: Clinical Management
14:00-18:00                             Session 5: Laboratory

Venue: Session Room 9
09:00-13:00                             Session 3: Infection Control
14:00-18:00                             Session 6: Ethical issues

Venue: Session Room 8
09:00-13:00                             Session 4: Health Information Systems
14:00-18:00                             Session 7: Drug Supply

Friday 30 October | Closing Session

Venue: Session Room 1 – Left Wing
09:00-12:00                             Closing Session

The facilitators of the morning sessions can be participants in the relevant afternoon sessions and vice versa. There is a limitation of 30 maximum participants per session.

________________________________________________________________________

Wednesday 28 October | Plenary Session

9:00-11:00

Welcome Address and Keynote Speeches
Venue: Session Room 1 – Left Wing

HE Dr Barnabas Sibusiso Dlamini, Prime Minister, Kingdom of Swaziland (tbc),
Hon Benedict Xaba, Minister of Health, Kingdom of Swaziland,
Mr Aymeric Peguillan, Head of Mission, MSF Swaziland,
Dr Mario Raviglione, Director, STOP TB Department, WHO
Prof Alan Whiteside, Executive Director HEARD, University of Kwazulu-Natal, South Africa

11:30-12:30

Opening Session
Venue: Session Room 1 – Left Wing

Global epidemic situation
Dr Samson Kefas, TB Medical Officer, WHO Swaziland

National epidemic situation
Ms Rejoice Nkambule, Deputy Director of Health Services and Public Health, Swaziland

12:30-13:00

Workshop orientation
Venue: Session Room 1 – Left Wing

Sessions and objectives
Dr Felipe Garcia de la Vega, MD Peds DTCH, MSF Swaziland

14:00-17:30

Introduction to Session 1: Health Systems
Swaziland National Health System: Governance of HIV/TB programs, health workforce & financing, regional partnerships, health information system, drugs and supplies procurement, role of the civil society and local communities, policies on HIV/TB & DR-TB.
Venue: Session Room 1 – Left Wing
Chair: Dr Giuliano Gargioni, Stop TB Department, WHO

14:00     National TB Control Program and Swaziland National AIDS Program
Mr Themba Dlamini, Manager, National TB Control Program
Dr Velephi Okello, National ART Coordinator, SNAP

14:20     Swaziland National DST Survey, Preliminary Results
Dr Elisabeth Sanchez-Padilla, Epicentre, France

14:40     Discussion

15:00     Swaziland Network of People Living with HIV/AIDS,
Representative of SWANNEPHA

15:20     Influence of donors and implementing partners on changes of the health system in Swaziland – Representative of URC

15:40     Swaziland – Shiselweni region experience,
Dr Hermann Reuter, MSF Swaziland

16:00     Discussion

17:00     Wrap Up and Outline
Dr Peter G. Faussett, Professor of International Health, London School of Hygiene & Tropical Medicine

19:00     Regional debate on models of health care
Lesotho, Dr Hind Satti  / South Africa KwaZulu Natal, Dr Bruce Margot / South Africa Khayelitsha, Dr Eric Gomaere

11:00-11:30 Coffee, 13:00-14:00 Lunch

________________________________________________________________________

Thursday 29 October | Sessions

Session 1: Health Systems
What is currently the most appropriate public health model for addressing the regional crisis due to the combined DR-TB / HIV-AIDS epidemics?
Venue: Session Room 7
Time:     9:00-13:00 & 14:00-18:00
Chairs:  Prof Anthony Harries, IUATLD (video link)
Prof Wim Van Damme, IMT, Antwerp, Belgium

Additional Presentation: Khayelitsha, South Africa MSF OCB project presentation

How to optimize the Swazi Health System, in order to reach out rural communities with HIV/TB services: case detection and patient flow for HIV and TB infections, provision of decentralized treatment, home-based management? How to adjust the Swazi health workforce to the needs of the current dual epidemic: core competencies, task shifting, training needs, legal frameworks? What are the roles and entitlements of community actors: community health workers, lay people and expert patients: PSEC, IEC, drug management? Policies for harmonization and support to TB-infected migrant workers in the South African region

11:00-11:30 Coffee, 13:00-14:00 Lunch


Session 2: Clinical Management of DR-TB
What are recommended standards for clinical management of DR-TB, keeping a balance between the urgency of mass treatment and the need to quality of care?
Venue: Session Room 10
Time:     9:00-13:00
Chair:    Dr Michael Rich, Country Director, Partners in Health Rwanda

Minimal standards for infection control of tuberculosis to be put in place in Swaziland: health facility and community levels?
Criteria for periods of isolation and of residual infectivity
Monitoring the impact of IC measures


11:00-11:30 Coffee, 13:00-14:00 Lunch

Session 3: Infection Control
What are the minimal regional standards for infection control of tuberculosis in the health facilities and in the communities?
Venue: Session Room 9
Time:     9:00-13:00
Chair:    Prof Saheen Methar, Head of Academic Unit for Infection Prevention and Control, Tygerberg Hospital & Stellenbosch University

Minimal standards for infection control of tuberculosis to be put in place in Swaziland: health facility and community levels?
Criteria for periods of isolation and of residual infectivity
Monitoring the impact of IC measures

Session 4: Health Information Systems
What are the best solutions to strengthen Health Information Systems in Swaziland and the best strategies to integrate data from different sources?
Venue: Session Room 8
Time:     9:00-13:00
Chair:    Dr Denis Falzon, STOP TB Department, WHO

Individual follow-up of HIV-TB patients, epidemiological monitoring, and programme performance monitoring.
What are the existing standards in a decentralized setting (manual data recording vs. computer-based system)?
What are current strengths and weaknesses of HIS in Swaziland?
How to improve integration between: HIV clinical data, TB clinical data, laboratory data, and drug supply systems?
Data protection (legal and technical aspects)


11:00-11:30 Coffee, 13:00-14:00 Lunch

Session 5: Laboratory
What minimal laboratory resources at what level and what type should be put in place in Swaziland to deal with the epidemics?
Venue: Session Room 10
Time:     14:00-18:00
Chair:    Dr Sabine Rüsch-Gerdes, National Reference Center for Mycobacteria, Borstel, Germany

What minimal laboratory/human resources should be put in place? At what level? What type? Reagent Management
What are recommended laboratory algorithms for the diagnostic of DR-TB in the Swazi context?
Current technologies and their local/regional availability? Regional networks? Quality control?
Future vision for diagnostics in Swaziland: Role of laboratory technologists, laboratory technicians and MD Biologists

11:00-11:30 Coffee, 13:00-14:00 Lunch

Session 6: Ethical Issues
What are the main Ethical dilemmas in the management of DR-TB patients in Southern Africa?
Venue: Session Room 9
Time:     14:00-18:00
Chair:    Prof Jerome Amir Singh, Research Ethics Board, MSF International

Ethical issues posed by DR-TB: isolation, chronic defaulters, palliative care?
Regional experiences?
To what extent the recommended IC measures (session 3) ease ethical problem?
Current legal framework on forcible isolation in Swaziland?
Orientation on key ethical dilemmas: employer initiated or enforced HIV testing, cost of drugs, lack of access to treatment due to shortage of drugs and staff to administer them, and the responsibility of the state with regards to patients experiencing permanent side effects (deafness) or temporary but highly stigmatizing (psychosis) at community level


11:00-11:30 Coffee, 13:00-14:00 Lunch

Session 7: Drug Supply
How can uninterrupted supply of quality drugs be ensured at all levels of health care system?
Venue: Session Room 8
Time:     14:00-18:00
Chair:    Dr Myriam Henkens, International Medical Coordinator, MSF

Ministry of Health Representative:
Ms Prudence Gwebu (TB Pharmacist, Swaziland)

What is the best design of a supply line management for HIV and (DR-TB) drugs in a decentralised setting like Swaziland? How to ensure quality monitoring?

11:00-11:30 Coffee, 13:00-14:00 Lunch

________________________________________________________________________

Friday 30 October | Closing Session

9:00-12:00

Rapporteurs’ summaries – Final Wrap Up
Venue: Session Room 1 – Left Wing

9:00        Health Systems
Dr Zerihun Tefera & Dr Martha Bedelu

9:20        Clinical Management of DR-TB
Dr Hermann Reuter & Dr Dmytro Donchuk

9:40        Infection Control
Ms Ana de Souza

10:00     Health Information Systems
Dr Philippe Calain

10:20     Laboratory
Biol Maryvonne Lassovski & Dr Frauke Jochims

10:40     Ethical issues
Mr Nathan Ford & Ms Elaine Texeira

11:00     Drug Supply
Ms Juanita Cristina Theodora

11:30     Final Wrap Up – Concluding Remarks
                Ms Rejoice Nkambule, Mr Bruno Jochum & Mr Aymeric Peguillan

12:30-14:00 Lunch

End of the Workshop

________________________________________________________________________

Practical details for the workshop

Venue: Esibayeni Lodge, Matsapha, P.O Box 1451, Manzini, Swaziland
Tel: +268 518 48 48
There will be free wireless internet access during the workshop for all participants

Médecins Sans Frontières/Doctors Without Borders (Switzerland)
Plot 392, Lukhalo Street, Dalriach East, Mbabane
Tel office: +268 404 83 07
Fax office: +268 404 78 84

International Consultative Workshop Coordination Team

Head of Swaziland Mission (Interim)
Mr Elias Pavlopoulos
Cell: +268 618 2622, Email: msfch-swaziland-workshop@geneva.msf.org

Workshop Coordinator
Dr Felipe Garcia de la Vega MD Peds DTCH
Cell: +268 6 111 864, Email: felipe.garcia@geneva.msf.org

Workshop Organiser
Ms Angela Vilakazi
Cell: +268 692 0387, Email: msf.mba.wshop@gmail.com  

Members of the Organising Committee

Chair: Ms. Rejoice Nkambule
Deputy Director of Health Services and Public Health, Swaziland Ministry of Health

Mr Aymeric Péguillan
Head of Swaziland Mission, Médecins Sans Frontières Switzerland

Dr Velephi Okello
ART Coordinator, Swaziland National AIDS Programme (SNAP)

Dr Marianne Calnan
ART Case Manager, Swaziland National AIDS Programme (SNAP)

Mr Themba Dlamini
Programme manager, National TB Control Programme (NTCP)

Ms Gugu Shongwe
TB/HIV Coordinator, National TB Control Programme (NTCP)

Dr Kamal Mohammed
National TB Clinical Coordinator, NTCP Swaziland

Ms Sphiwe Ngwenya
TB Coordinator (Shiselweni), NTCP Swaziland

Dr Hosea Sukati
Head of the National Blood Program and National Clinical Laboratories

Mr Derick Khumalo

TB Laboratory Coordinator, National Blood Program and National Clinical Laboratories

Ms Prudence Gwebu
TB Pharmacist, Swaziland

Ms Thembi Dlamini
Coordinator, Treatment, Care and Support, National Emergency Response Council on HIV/AIDS (NERCHA)

Dr Samson Kefas
TB Medical Officer, STOP TB Department, WHO Swaziland

Dr Samson Malwa Huamba
MBCH B M. MED (Intern. Med) MPH, Country Director – University Research Co., LLC, Swaziland

Dr Yohannes Ghebreyesus
Drug Resistant TB Coordinator, University Research Co., LLC, Swaziland

 

2009 © MÉDECINS SANS FRONTIÈRES / DOCTORS WITHOUT BORDERS (MSF)